Co-Diagnostics has signed an agreement to acquire certain technologies from DNA Logix for genetic analysis in the clinical, industrial and bio-threat markets. The technology to be acquired facilitates rapid assay development and reduced ...
Co-Diagnostics has signed an agreement with DNA Logix, a molecular diagnostic assays developer, to buy certain technologies for genetic analysis in the clinical, industrial, and bio-threat segments. The technology to be gained is embodied ...
Tags: Suite of Technologies, Medicine